Target intelligence / Profile preview

Beta-oxidation pathway terminal enzyme

Molecular classification
Enzyme
01

Overview

The term "Beta-oxidation pathway terminal enzymes" is not a standard name for a single molecular target but rather refers collectively to the enzymes that catalyze the final steps in the beta-oxidation of fatty acids. Beta-oxidation is a mitochondrial process by which fatty acids are broken down into acetyl-CoA, NADH, and FADH₂ for energy production[2][3][5]. The canonical sequence of enzymatic reactions in each cycle includes: 1. Acyl-CoA dehydrogenase (first oxidation) 2. Enoyl-CoA hydratase (hydration) 3. 3-hydroxyacyl-CoA dehydrogenase (second oxidation) 4. β-ketothiolase, also known as thiolase (thiolytic cleavage)[1][3][5] The "terminal enzyme" of each cycle is β-ketothiolase, which cleaves the two-carbon acetyl group from the acyl chain[1][5]. There are multiple isoforms of these enzymes depending on substrate chain length. Because "Beta-oxidation pathway terminal enzymes" does not refer to a specific protein or gene but rather an enzymatic function within a metabolic pathway, it cannot be considered a therapeutic target in itself; instead, individual enzymes within this pathway may be targets or biomarkers for certain metabolic diseases[2][3]. If you require structured information about specific beta-oxidation enzymes—such as "Acyl-CoA dehydrogenase," "Enoyl-CoA hydratase," or "β-ketothiolase"—please specify which enzyme so that detailed data can be provided accordingly.

02

Biological functions

Fatty acid catabolismEnergy production
03

Disease associations

Metabolic disorders (e.g., fatty acid oxidation disorders)
04

Safety considerations

Deficiency or dysfunction can lead to metabolic diseases such as medium-chain acyl-CoA dehydrogenase deficiency (MCADD) and other fatty acid oxidation disorders.

Beyond the preview

Go deeper on Beta-oxidation pathway terminal enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-oxidation pathway terminal enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call